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Abstract
A 60-year-old Caucasian male underwent a total pancreatectomy for a mixed type pancreatic intraductal papillary
mucinous neoplasm (IPMN) arising in the main and secondary pancreatic ducts. During surgery, a subserosal poly-
poid mass was noted at the greater curvature of the gastric antrum and was enucleated. This mass was proven to
be heterotopic pancreatic tissue with cystic neoplasia of the IPMN histologic subtype. Through an extensive search
of the literature, we found that this is the first case ever reported with simultaneous existence of IPMN changes, in
the main and secondary ducts of the orthotopic pancreas and in the heterotopic pancreatic tissue of the gastric
wall.
Introduction
Recent literature suggests either an increasing incidence
of cystic neoplasms of the pancreas, or improved detec-
tion and recognition of these lesions. Historically,
autopsy studies have revealed a significant prevalence of
cystic lesions of the pancreas. Kimura et al [1] found cys-
tic lesions in 24% of 300 consecutive autopsy specimens
among an elderly Japanese population. The most signifi-
cant recent change in the diagnosis and treatment of
pancreatic cystic neoplasms is the recognition of intra-
ductal papillary mucinous neoplasm (IPMN) as a distinct
pathologic entity [2-6]. First reported in the literature by
Ohashi et al [7], it was classified as a distinct entity from
other mucin-producing cystic neoplasms of the pancreas
by the World Health Organization (WHO) in 1996 [8].
Characteristic features of IPMN according to WHO
include a tall, columnar epithelium with marked mucin
production, and cystic transformation of either the main
pancreatic duct or one of its side branches [8,9].
Despite the fact that IPMNs have become the second
most common cause of pancreatic resections at many
large centers [10], the incidence of this pathologic entity
in heterotopic pancreatic tissue is extremely rare. It is
not unusual to find pancreatic tissue in the stomach,
duodenum, ileum, Meckel’s diverticulum or at the umbi-
licus. Feldman and Weinberg [11] found duodenal pan-
creatic tissue in 13,7% of 410 necropsy specimens.
Pearson [12] estimated that heterotopic pancreatic tissue
could be found in as many as 2% of autopsies if it were
sought carefully. In spite of the relatively common pre-
sence of heterotopic pancreas, mainly as a silent gastro-
intestinal malformation, a systematic review of the
literature has revealed only one reported case of papil-
lary mucinous neoplasm in gastric polypoid tumor con-
taining heterotopic pancreatic tissue [13].
Herein, we report a case of pancreatic IPMN from the
main and secondary pancreatic ducts with simultaneous
existence of a gastric polypoid tumor containing hetero-
topic pancreatic tissue with cystic neoplasia of the same
histologic subtype.
Case report
A 60-year-old man visited his physician because of a
skin discoloration suggestive of jaundice, dark urine and
pale stools. The patient also reported vague epigastric
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icterus. He denied any fever or weight loss. His medical
history also included hypertension, diabetes mellitus and
tuberculosis. A complete blood cell count was taken,
which revealed no abnormality, while the blood chemis-
try profile demonstrated direct hyperbilirubinemia (total
bilirubin, TBIL:20 mg/dl, direct bilirubin, DBIL:16 mg/
dl) and a remarkable elevation of the alkaline phospha-
tase (ALP) and gamma-glutamyl transpeptidase (GGT)
(the levels of aspartate transaminase (AST) and alanine
transaminase (ALT) were only mildly elevated). The
patient was subjected to ultrasound examination of his
abdomen which disclosed a cystic mass in the head of
the pancreas and a dilatation of the common bile duct
(1.7 cm) and intrahepatic bile ducts.
The patient was further evaluated with T1-weighed and
T2-weighed gadolinium ((Gd)-DTPA)-enhanced MRI
images and MRCP, which revealed a cystic lesion in the
pancreatic head with maximum transverse diameter of 5
cm. The pancreatic cyst was in communication with a
clearly dilated main pancreatic duct. In parallel with the
dilatation of the main pancreatic duct along its entire
course, a significant dilatation of secondary ducts (side-
branches) was also documented (Figure 1). The imaging
findings were compatible with the diagnosis of a diffusely
distributed intraductal papillary mucinous neoplasm
(IPMN) of the mixed-type variety. Moreover, the ultraso-
nographic finding of the dilated intra- and extra-hepatic
biliary tree was confirmed, with maximum diameter of the
common bile duct at about 1,7 cm. Due to the level of
icterus and the coexisting dilation of the common bile
duct (CBD), the patient was subsequently subjected to
ERCP with simultaneous insertion of a plastic stent into
the CBD. During the upper gastrointestinal endoscopy,
only a mild esophagitis of the lower third of the esophagus
was diagnosed, with no indication of a gastric wall
abnormality reported.
After the aforementioned complete work-up of the
patient, he was referred to our Surgical Department for
surgical treatment. Because of the diffuse distribution of
the cystic neoplasm, a total pancreatectomy, splenectomy
and limited partial gastrectomy was performed. Inciden-
tally a subserosal polypoid tumor was found at the greater
curvature of the gastric antrum. Local excision of the gas-
tric tumor was performed and it was also sent for histolo-
gic examination. On the 6
th postoperative day, the patient
presented a biliary leak which was managed conservatively.
He was discharged on the 40
th day, and 1 year after the
operation has been disease and symptom free.
Histologic examination of the orthotopic pancreas
revealed a non-invasive intraductal papillary mucinous
neoplasm involving the main pancreatic duct, with promi-
nent intraductal papillary projections (Figure 2a). The
papillae were well-developed with a fibrovascular core.
The neoplastic epithelial cells showed intestinal differen-
tiation. The neoplasm exhibited significant architectural
and nuclear atypia. There was budding off of clusters of
neoplastic cells into the lumen, as well as, significant
nuclear pleomorphism with loss of polarity and prominent
nucleoli (IPMN with high grade dysplasia; figure 2b).
A d d i t i o n a l l y ,a2 . 5×2 . 2×0 . 9c mm e a s u r i n gt i s s u e
specimen from the gastric wall was received. Macro-
scopic evaluation revealed a 1.5 cm white nodule with
cystic spaces. Histological examination demonstrated
heterotopic pancreatic tissue consisting of well-formed
lobules of pancreatic acini and cystically dilated ducts
containing intraluminal papillae (Figure 3a, b). The
papillary structures were lined by mucinous epithelium
with focal intestinal metaplasia and mild to moderate
nuclear atypia (Figure 3b, c).
Discussion
IPMNs account for 7-35% of all the cystic neoplasms of
the pancreas in published surgical series [14,15]. In con-
trast to patients with serous cystic neoplasms (SCN) or
mucinous cystic neoplasms (MCN), patients with IPMN
tend to be older, with a mean age at presentation of
approximately 65 years. In the differential diagnosis of
IPMN MCN and pancreatic intraepithelial neoplasia
(PanIN) must be included [16,17]. MCNs usually can be
distinguished by the lack of pancreatic ductal structures
and their characteristic ovarian-like stroma. Distinction
of IPMNs from PanINs may be more difficult and has
been the subject of an international consensus confer-
ence in August 2003 [17]. While IPMNs are of macro-
scopically visible size, PanINs are microscopic findings
involving ducts less than 5 mm [17]. Moreover, IPMNs
often express the mucin MUC-2, while PanINs usually
express MUC-1.
Figure 1 MRCP showing pancreatic cyst in the head of the
organ with dilation of the main and branch pancreatic ducts
as well as of the extra- intra hepatic biliary tree.
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pancreatic tissue that lacks direct or vascular connection
to normal pancreas [18]. In autopsy series, the preva-
lence of this congenital condition ranges from 0,55% to
13,7% [19]. Clinically, pancreatic heterotopia is observed
in one out of 500 upper abdominal operations [20].
Pearson et al [12] reviewed 589 cases of heterotopic
pancreas, and reported the frequencies of this disorder
as follows: 30% in the duodenum, 25% in the stomach,
15% in the jejunum, 3% in the ileum and 6% in Meckel’s
diverticulum. Particularly in the stomach, heterotopic
pancreatic tissue predominantly develops in males
between 30 and 50 years of age. The majority of cases
identified in the stomach are submucosal tumors,
located in the antrum [21].
T h ep r e s e n c eo fh e t e r o t o p i cp a n c r e a si su s u a l l y
asymptomatic, but it is capable of producing symptoms,
depending on its location and size [22]. Several cases
have been reported in the literature presenting as gastric
outlet obstruction, small bowel obstruction, upper gas-
trointestinal bleeding or obstructive jaundice [23-26].
Adenocarcinoma, islet cell tumors and cystic tumors
have also been reported in heterotopic pancreas
[19,27-29].
In the literature, there are few reported cases of malig-
nant change of ectopic gastric pancreas [30,31]. The
majority of these cases represent adenocarcinoma, while
papillary mucinous neoplasia, of whatever histologic sub-
type, has been reported in only one case so far [13]. The
present case is the first reported with the unique charac-
teristic of simultaneous existence of IPMN (of the mixed
pancreatic duct type) and IPMN or PanIN of the heteroto-
pic gastric pancreatic tissue. Our case satisfies the minimal
diagnostic criteria for tumors that arise in heterotopic pan-
creatic tissue initially proposed by Guillou and colleagues
[29] which state that: i. the tumor must be found within or
a
b
Figure 2 IPMN in orthotopic pancreas. a. Well-developed
papillary projections within the duct. There is architectural and
nuclear atypia. (H+E ×200), b. Budding off of clusters of neoplastic
cells into the lumen (H+E ×400).
a 
b 
c 
Figure 3 a. Ectopic pancreatic tissue within the gastric wall (H
+E ×100), b. and c. Cystically dilated ducts containing intraluminal
papillae. The papillary structures are lined by mucinous epithelium
with nuclear atypia, consistent with IPMN (H+E ×400).
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pancreatic structures and carcinoma must be observed
(ie duct cell dysplasia or carcinoma in situ), iii. the non-
neoplastic pancreas must comprise at least fully developed
acini and ductal structures, and iv. direct extension or
metastasis from an other site must be excluded.
The differential diagnosis in this case (as regards the
ectopic gastric pancreatic tissue) includes low-grade
intraepithelial neoplasia and small IPMN. As previously
emphasized such distinction is impossible at times and
currently is based on size and macroscopic appearance
[32]. Since the lesion described was noted on gross
inspection of the surgical specimen, we believe that the
designation of intraductal papillary mucinous neoplasm
would be more appropriate. Moreover, the papillary
excrescences are larger than those typically seen in
PanIN.
The preoperative diagnosis of heterotopic pancreas is
challenging despite the advances in imaging technology.
Heterotopic pancreas usually presents in upper gastroin-
testinal series as a well-delineated submucosal filling
defect with a central indentation [20,33,34]. Endoscopi-
cally, the lesion is seen as a submucosal tumor with a
central umbilication. The CT imaging of an ectopic pan-
creas enhances brightly as an orthotopic pancreas [29,35].
Given its clinically insidious course, heterotopic pan-
creas is usually an incidental finding, either intraoperati-
velly, or during radiographic or endoscopic examination
of the upper gut. When found at the time of laparotomy
(as in our case), local excision, with or without frozen
section, rather than radical resection is the preferred
way of treatment [25,33,36]. Potentially, however, the
documentation of underlying malignancy based on the
implemented frozen section analysis, sets the dilemma
of performing a more radical surgical treatment in order
to prevent re-operation or diagnostic difficulties.
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